OTC Link · Healthcare · Drug Manufacturers - Specialty & Generic
PROPHASE LABS INC
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-19 | Q3 2025 | -0.11 | -0.16 | -45.45% | $883,000 | ❌ Miss | — | — | — |
| 2025-08-13 | Q2 2025 | -0.15 | -0.11 | +26.67% | $1.2M | mixed | -1.13% | +0.73% | +32.41% |
| 2025-03-31 |
| Q4 2024 |
| -1.27 |
| -1.59 |
| -25.20% |
| $-2.5M |
| ❌ Miss |
| -0.07% |
| -32.95% |
| -13.93% |
| 2024-11-13 | Q3 2024 | 0.04 | -0.35 | -975.00% | $3.1M | ❌ Miss | -2.42% | -0.65% | -15.45% |
| 2024-08-14 | Q2 2024 | -0.24 | -0.33 | -37.50% | $2.5M | ❌ Miss | -9.60% | +13.20% | -2.00% |
| 2023-08-10 | Q2 2023 | -0.14 | -0.20 | -42.86% | $13.2M | ❌ Miss | -2.23% | -14.15% | -30.21% |
| 2023-05-11 | Q1 2023 | -0.09 | 0.03 | +133.33% | $19.3M | ✅ Beat | -6.71% | -0.24% | -12.82% |
| 2023-03-28 | Q4 2022 | 0.02 | -0.08 | -500.00% | $21.8M | ❌ Miss | -6.51% | -7.12% | -8.44% |
Showing last 8 quarters.